MET and cancer: EGFR, KIT, MET, PPARG, and STAT5A were enriched in the Pathways in cancer, CAV1, EGFR, and MET were enriched in the Proteoglycans in cancer, and MET and PPARG were enriched in the Transcriptional misregulation in cancer.